Oncology

Back to articles

Pembrolizumab shows promise for advanced melanoma

KEY POINT

Results of a recent study showed that pembrolizumab (Keytruda—Merck) may be an effective treatment for patients with certain types of advanced melanoma whose treatment failed with use of ipilimumab (Yervoy—Bristol–Myers Squibb)."